USF researchers have developed novel hyaluronic acid and hyaluronic acid hybrid nanoparticles for transdermal drug delivery. These nanoparticles can encapsulate peptides, DNA, and small molecules. They also allow for the controlled release of the active molecules that they are transporting. The nanoparticles are at most 180 nm in diameter, making them an attractive candidate for cell specific drug delivery. These nanoparticles are made from natural polymers, are biocompatible and biodegradable, and are well suited for gene or chemotherapy treatment.
An Example of a Solid Lipid Nanoparticle Used for Drug Delivery